Print

Supernus Pharmaceuticals (SUPN) Announces Resignation of Board Member  
11/1/2012 7:23:15 AM

ROCKVILLE, Md., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, announced today that Michael Sheffery, a General Partner at OrbiMed Advisors, LLC has resigned from the company's board of directors, effective October 29, 2012.
//-->